Hormone Therapy for Thyroid Cancer

 

The thyroid gland makes a hormone (thyroid hormone) that helps control your heart rate, body temperature, and energy level. A gland in your brain (pituitary gland) constantly monitors the amount of thyroid hormone in your blood. If you do not have enough thyroid hormone, your pituitary releases extra thyroid-stimulating hormone (TSH), which tells your thyroid to absorb iodine from the blood and use it to make more thyroid hormone. Your thyroid gland then makes and releases the hormone directly into your bloodstream. Your pituitary gland senses that the right amount of thyroid hormone is moving through your body, so it slows its production of TSH back to normal.

After you have any kind of thyroid surgery, your body will no longer be able to make the thyroid hormone it needs. You will therefore need to take thyroid hormone replacement pills to give your body the natural thyroid hormone it can no longer make on its own. If you have follicular or papillary cancer, the thyroid hormone pills can also slow down the growth of any cancer cells that are left in your body. The generic name of the hormone is levothyroxine sodium. It is sold as Synthroid®, Levoxyl®, Levothroid®, Unithroid®, and other brand names.

This content has been reviewed and approved by Myo Thant, MD.
This content was last modified on September 19, 2007 .
Latest Cancer News
Zevalin® Confirmed Effective for Patients with Follicular Lymphoma Who Have Failed an Autologous Transplant

September 5, 2008 — Researchers from France have reported that five of eight patients with follicular lymphoma who had failed an autologous stem cell transplant achieved a complete remission with standard doses of Zevalin® (Yttrium-90 ((90)Y) ibritumomab tiuxetan). The details of this study appeared in an early online publication in Leukemia-Lymphoma of July 15, 2008.

Forty Percent of Postmenopausal Breast Cancers Preventable by Lifestyle Changes

September 5, 2008 — Researchers from the University of Wisconsin-Madison, the H. Lee Moffitt Cancer Center, Dartmouth Medical School, and the Fred Hutchinson Cancer Center have reported that 40.7% of postmenopausal breast cancer can be prevented by changes in lifestyle. The details of this study appeared in the August 15, 2008 issue of the American Journal of Epidemiology.

US FDA lists drugs under safety probes

September 5, 2008 — WASHINGTON (Reuters) - U.S. health officials said on Friday they are probing safety concerns with Eli Lilly and Co's antidepressant Cymbalta, Biogen Idec and Elan Corp's multiple sclerosis drug Tysabri and more than a dozen other medicines.

Select news items provided by Reuters Health